Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Feb. 16, 2023, 21:30 UTC
  • 27
  • 0 comments

FDA approve NIVOLUMAB

Comment Full text

LUPIN LTD

  • FDA Approval
  • Feb. 16, 2023, 16:16 UTC
  • 29
  • 0 comments

FDA approve EFINACONAZOLE

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Feb. 16, 2023, 16:16 UTC
  • 27
  • 0 comments

FDA approve CEFAZOLIN SODIUM

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Feb. 16, 2023, 16:16 UTC
  • 29
  • 0 comments

FDA approve OSELTAMIVIR PHOSPHATE

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • Feb. 15, 2023, 19:09 UTC
  • 31
  • 0 comments

FDA approve CANAGLIFLOZIN

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • Feb. 15, 2023, 18:50 UTC
  • 35
  • 0 comments

FDA approve BOSENTAN

Comment Full text

SANDOZ INC

  • FDA Approval
  • Feb. 15, 2023, 18:25 UTC
  • 31
  • 0 comments

FDA approve IBRUTINIB

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Feb. 15, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

BRECKENRIDGE PHARM

  • FDA Approval
  • Feb. 15, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text

CAPLIN

  • FDA Approval
  • Feb. 15, 2023, 12:38 UTC
  • 31
  • 0 comments

FDA approve CARBOPROST TROMETHAMINE

Comment Full text
  • Previous
  • 880
  • 881
  • 882
  • 883
  • 884
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6229)
  • SEC News(264747)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154624)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin